Journal of Autism and Developmental Disorders

, Volume 41, Issue 10, pp 1373–1382 | Cite as

Treatments for Autism: Parental Choices and Perceptions of Change

  • Anne Bowker
  • Nadia M. D’Angelo
  • Robin Hicks
  • Kerry Wells
Original Paper

Abstract

Empirically conducted studies of the efficacy of various treatments for autism are limited, which leaves parents with little evidence on which to base their treatment decisions (Kasari, Journal of Autism and Developmental Disorders, 32: 447–461, 2002). The purpose of this study was to examine the types of treatments in current use by families of children with ASD. In addition, parents’ perceptions of improvement in their child’s functioning were explored. Through an online survey, a sample of 970 parents of ASD children reported on the treatments currently in use, those discontinued, and reasons for discontinuation. Results indicate that most families adopt multiple treatment approaches. Parents were most likely to discontinue non-evidence based treatments when they did not see improvement in their child’s functioning.

Keywords

Autism Treatment Parent perception 

References

  1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders IV-TR (text revision). Washington, DC: American Psychiatric Association.CrossRefGoogle Scholar
  2. Campbell, M., Schopler, E., Cueva, J. E., & Hallin, A. (1996). Treatment of autistic disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 35, 134–143.CrossRefGoogle Scholar
  3. Dawson, G., & Watling, R. (2000). Interventions to facilitate auditory, visual, and motor integration in autism: a review of the evidence. Journal of Autism and Developmental Disorders, 30, 415–421.PubMedCrossRefGoogle Scholar
  4. Dillenburger, K., Keenan, M., Gallagher, S., & McElhinney, M. (2004). Parent education and home-based behaviour analytic intervention: an examination of parents’ perceptions of outcome. Journal of Intellectual & Developmental Disability, 29, 119–130.CrossRefGoogle Scholar
  5. Fombonne, E. (2005). Epidemiological studies of pervasive developmental disorders. In F. R. Volkmar, R. Paul, A. Klin, & D. Cohen (Eds.), Handbook of autism and pervasive developmental disorders (pp. 42–69). Hoboken, NJ: John Wiley & Sons, Inc.Google Scholar
  6. Goin-Kochel, R. P., Mackintosh, V. H., & Myers, B. J. (2009). Parental reports on the efficacy of treatments and therapies for their children with autism spectrum disorders. Research in Autism Spectrum Disorders, 3, 528–537.CrossRefGoogle Scholar
  7. Goin-Kochel, R. P., Myers, B. J., & Mackintosh, V. H. (2007). Parental reports on the use of treatments and therapies for children with autism spectrum disorders. Research in Autism Spectrum Disorders, 1, 195–209.CrossRefGoogle Scholar
  8. Green, V. A. (2007). Parental experience with treatments for autism. Journal of Developmental Physical Disabilities, 19, 91–101.CrossRefGoogle Scholar
  9. Green, V. A., Pituch, K. A., Itchon, J., Choi, A., O’Reily, M., & Sigafoos, J. (2006). Internet survey of treatments used by parents of children with autism. Research in Developmental Disabilities, 27, 70–84.PubMedCrossRefGoogle Scholar
  10. Heflin, L. J., & Simpson, R. L. (1998). Interventions for children and youth with autism: Prudent choices in a world of exaggerated claims and empty promises. Part 1: Intervention and treatment option review. Focus on Autism and Other Developmental Disabilities, 13, 194–211.CrossRefGoogle Scholar
  11. Hume, K., Bellini, S., & Pratt, C. (2005). The usage and perceived outcomes of early intervention and early childhood programs for young children with autism spectrum disorder. Topics in Early Childhood Special Education, 25, 195–207.CrossRefGoogle Scholar
  12. Kasari, C. (2002). Assessing change in early intervention programs for children with autism. Journal of Autism and Developmental Disorders, 32, 447–461.PubMedCrossRefGoogle Scholar
  13. Kern, J. K., Espinoza, E., & Trivedi, M. (2004). The effectiveness of secretin in the management of autism. Expert Opinion Pharmacotherapy, 5, 379–387.CrossRefGoogle Scholar
  14. Levy, S. E., & Hyman, S. L. (2002). Alternative/Complementary approaches to treatment of children with autism spectrum disorders. Infants and Young Children, 14, 33–42.CrossRefGoogle Scholar
  15. Levy, S. E., & Hyman, S. L. (2005). Novel treatments for autistic spectrum disorders. Mental Retardation and Developmental Disabilities, 11, 131–142.CrossRefGoogle Scholar
  16. Lord, C., & Schopler, E. (1988). Intellectual and developmental assessment of autistic children from preschool to school age: Clinical implications of two follow-up studies. In G. Mesibov & E. Schopler (Eds.), Diagnosis and assessment in Autism (pp. 167–181). New York, NY: Plenum Press.Google Scholar
  17. Metz, B., Mulick, J. A., & Butter, E. M. (2005). Autism: A late-20th–century fad magnet. In J. W. Jacobson, R. M. Foxx, & J. A. Mulick (Eds.), Controversial therapies for developmental disabilities: Fad, fashion and science in professional practice (pp. 237–263). Mahwah, NJ: Lawrence Erlbaum Associates.Google Scholar
  18. New York State Department of Health Early Intervention Program (1999). Clinical practice guidelines: Report of the recommendations on autism and pervasive developmental disorders. New York: State Department of Health. Retrieved March 23, 2005 from www.health.state.ny.us/nysdoh/eip/menu.htm.
  19. Sandler, A. (2005). Placebo effects in developmental disabilities: Implications for research and practice. Mental Retardation and Developmental Disabilities Research Reviews, 11, 164–170.PubMedCrossRefGoogle Scholar
  20. Smith, T. (1999). Outcome of early intervention for children with autism. Clinical Psychology: Science and Practice, 6, 33–49.CrossRefGoogle Scholar
  21. Sturmey, P. (2005). Secretin is an ineffective treatment for pervasive developmental disorders: a review of 15 double-blind randomized controlled trials. Research in Developmental Disabilities, 26, 87–97.PubMedCrossRefGoogle Scholar
  22. Tharp, B. (2003). Contributions of neurology. In S. Ozonoff, S. J. Rogers, & R. L. Hendren (Eds.), Autism spectrum disorders: A research review for practioners (pp. 111–129). Washington, DC, USA: American Psychiatric Publishing, Inc.Google Scholar
  23. Tidmarsh, L., & Volkmar, F. R. (2003). Diagnosis and epidemiology of autism spectrum disorders. Canadian Journal of Psychiatry, 48, 517–525. (electronic version).Google Scholar
  24. Volkmar, F. R., & Klin, A. (2005). Autism in infancy and early childhood. Annual Reviews of Psychology, 56, 315–336.CrossRefGoogle Scholar
  25. Yung, W. H., Leung, P. S., Ng, S. S., Zhang, J., Chan, S. C., & Chow, B. K. (2001). Secretin facilitates GABA transmission in the cerebellum. Journal of Neuroscience, 21, 7063–7068.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Anne Bowker
    • 1
  • Nadia M. D’Angelo
    • 1
  • Robin Hicks
    • 2
  • Kerry Wells
    • 3
  1. 1.Department of PsychologyCarleton UniversityOttawaCanada
  2. 2.Autism and Behavioural Science ProgramSt. Lawrence CollegeKingstonCanada
  3. 3.Department of PsychologyYork UniversityTorontoCanada

Personalised recommendations